The circadian clock protein REVERBα inhibits pulmonary fibrosis development

Peter Cunningham, Peter Meijer, Alicja Nazgiewicz, Simon Anderson, Lee A. Borthwick, James Bagnall, Gareth Kitchen, Monika Lodyga, Nicola Begley, Rajamiyer Venkateswaran, Rajesh Shah, Paul F. Mercer, Hannah Durrington, Neil Henderson, Karen Piper Hanley, Andrew Fisher, Rachel C. Chambers, David Bechtold, Julie Gibbs, Andrew LoudonMartin K. Rutter, Boris Hinz, David Ray, John Blaikley

Research output: Contribution to journal › Article › peer-review

2 results

Finished
MRC Transition Support CSF John Blaikley
Blaikley, J. (PI)
1/08/20 → 31/07/22
Project: Research
Investigation of REVERBalpha as a Therapeutic Target in Pulmonary Fibrosis.
Blaikley, J. (PI), Loudon, A. (CoI) & Ray, D. (CoI)
3/05/14 → 2/08/19
Project: Research